Huxley Rachel, Owen Christopher G, Whincup Peter H, Cook Derek G, Colman Sam, Collins Rory
The George Institute, University of Sydney, Royal Prince Alfred Hospital, Camperdown, Sydney, NSW, Australia.
JAMA. 2004 Dec 8;292(22):2755-64. doi: 10.1001/jama.292.22.2755.
Inverse associations between birth weight and subsequent blood cholesterol levels have been used to support the "fetal origins" hypothesis of the relevance of fetal nutrition to adult disease.
To perform a systematic review of the association between birth weight and total blood cholesterol levels, and to explore the impact of including unpublished results, adjusting for potential confounders.
Relevant studies published by September 30, 2004, were identified through literature searches using EMBASE and MEDLINE and MeSH heading search strategy (using terms such as birth weight, intrauterine growth retardation, fetal growth retardation and cholesterol, lipoprotein, lipid). Studies that reported qualitative or quantitative estimates of the association between birth weight and total blood cholesterol, or had recorded both measures but not reported on their associations, were included.
A total of 79 relevant studies involving a total of 74,122 individuals were identified; 65 had reported on the direction of the association between birth weight and total blood cholesterol. Although regression coefficients were published for only 11 studies and other quantitative estimates for 3 other studies, regression coefficients (published or unpublished) were obtained for 58 studies among 68,974 individuals.
Inverse associations were observed in 11 of 14 studies that had previously published quantitative estimates but in only 18 of the remaining 51 that had reported on the direction of this association (heterogeneity P = .004). Similarly, the weighted estimate for the 11 studies was -1.89 mg/dL (-0.049 mmol/L) total cholesterol per kilogram birth weight compared with -0.69 mg/dL (-0.018 mmol/L) per kilogram for 47 studies that provided unpublished regression coefficients (heterogeneity P = .009). Overall, the weighted estimate from the 58 contributing studies was -1.39 mg/dL (-0.036 mmol/L) per kilogram (95% confidence interval, -1.81 to -0.97 mg/dL [-0.047 to -0.025 mmol/L]), but there was significant heterogeneity between their separate results (P<.001). Part of this heterogeneity appears to reflect stronger associations reported from smaller studies and studies of cholesterol levels in infants.
These findings suggest that impaired fetal growth does not have effects on blood cholesterol levels that would have a material impact on vascular disease risk.
出生体重与后续血液胆固醇水平之间的负相关关系已被用于支持胎儿营养与成人疾病相关性的“胎儿起源”假说。
对出生体重与总血胆固醇水平之间的关联进行系统评价,并探讨纳入未发表结果、校正潜在混杂因素的影响。
通过使用EMBASE、MEDLINE及医学主题词(MeSH)检索策略(使用出生体重、宫内生长迟缓、胎儿生长迟缓以及胆固醇、脂蛋白、脂质等术语)进行文献检索,确定截至2004年9月30日发表的相关研究。纳入报告了出生体重与总血胆固醇之间关联的定性或定量估计值,或记录了这两项指标但未报告其关联情况的研究。
共识别出79项相关研究,涉及74122名个体;65项研究报告了出生体重与总血胆固醇之间关联的方向。虽然仅11项研究发表了回归系数,另外3项研究发表了其他定量估计值,但在68974名个体中的58项研究中获得了回归系数(已发表或未发表)。
在之前发表了定量估计值的14项研究中的11项观察到负相关,但在其余报告了该关联方向的51项研究中仅18项观察到负相关(异质性P = 0.004)。同样,11项研究的加权估计值为每千克出生体重总胆固醇降低1.89 mg/dL(-0.049 mmol/L),而47项提供未发表回归系数的研究为每千克降低0.69 mg/dL(-0.018 mmol/L)(异质性P = 0.009)。总体而言,58项参与研究的加权估计值为每千克降低1.39 mg/dL(-0.036 mmol/L)(95%置信区间,-1.81至-0.97 mg/dL [-0.047至-0.025 mmol/L]),但其各自结果之间存在显著异质性(P<0.001)。这种异质性部分似乎反映了较小研究以及婴儿胆固醇水平研究报告的更强关联。
这些发现表明,胎儿生长受限对血胆固醇水平没有实质性影响血管疾病风险的作用。